CD226 anticorps

N° du produit ABIN217695

Cet anticorps anti-CD226 est un anticorps Souris Monoclonal détectant CD226 dans FACS, IP et Func. Adapté pour Humain.

Aperçu rapide pour CD226 anticorps (ABIN217695)

Antigène: CD226

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD226 est non-conjugé

Application: Flow Cytometry (FACS), Immunoprecipitation (IP), Functional Studies (Func)

Clone: DX11

Détail du produit anti-CD226 anticorps

Specificité: Recognizes human CD226, a 65kD glycoprotein, also known as DNAM1 (DNAX accessory molecule-1). CD226 is broadly expressed on T-cells, NK cells, platelets, monocytes and a subset of B cells. CD226 is also expressed by a subset of CD3 positive thymocytes. Clone DX11 is reported to inhibit T- and NK cell mediated cytotoxicity against tumor cell targets and to block TNF alpha and IFN gamma secretion by alloantigen-specific T-cells.

Purification: Protein G purified

niveau d'endotoxine: Low Endotoxin

Immunogène: Human cytotoxic T lymphocyte clone.

Type of Immunogen: Cells

Isotype: IgG1

Information d'application

Indications d'application: Approved: Flo (1:50 - 1:200), Func, IP

Usage: The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. Flow Cytometry: Use 10 μL of the suggested working dilution to label 1 x 10^6 cells in 100 μL. Method sheets are available on request.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS.

Conseil sur la manipulation: Aliquot to Avoid freeze/thaw cycles. Store undiluted.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot to avoid freeze-thaw cycles. Store undiluted.

Détails sur CD226

Antigène: CD226

Autre désignation: DNAM-1 / CD226

Sujet: Name/Gene ID: CD226

Synonyms: CD226, Adhesion glycoprotein, CD226 Molecule, CD226 antigen, DNAM-1, DNAM1, DNAX accessory molecule-1, TLiSA1, PTA1, DNAX accessory molecule 1

ID gène: 10666

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints